Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.515 USD | -3.53% | -5.35% | +48.03% |
01/05 | Transcript : G1 Therapeutics, Inc., Q1 2024 Earnings Call, May 01, 2024 | |
01/05 | Earnings Flash (GTHX) G1 THERAPEUTICS Reports Q1 Revenue $14.5M, vs. Street Est of $15.1M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.03% | 24Cr | |
+9.13% | 11TCr | |
+11.47% | 10TCr | |
-13.99% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-3.72% | 1.79TCr | |
+7.76% | 1.43TCr | |
+34.89% | 1.25TCr |
- Stock Market
- Equities
- GTHX Stock
- News G1 Therapeutics, Inc.
- G1 Therapeutics Says Phase 2 Trial Shows Objective Response Rate of 40% in Patients With Bladder Cancer